These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16124011)

  • 21. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson's disease.
    Katayama Y; Oshima H; Kano T; Kobayashi K; Fukaya C; Yamamoto T
    Stereotact Funct Neurosurg; 2006; 84(4):176-9. PubMed ID: 16905880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective subthalamic nucleus deep brain stimulation sites may differ for tremor, bradykinesia and gait disturbances in Parkinson's disease.
    Hilliard JD; Frysinger RC; Elias WJ
    Stereotact Funct Neurosurg; 2011; 89(6):357-64. PubMed ID: 22104373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
    Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
    Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine replacement therapy and deep brain stimulation of the subthalamic nuclei induce modulation of emotional processes at different spatial frequencies in Parkinson's disease.
    Mermillod M; Mondillon L; Rieu I; Devaux D; Chambres P; Auxiette C; Dalens H; Coulangeon LM; Jalenques I; Durif F
    J Parkinsons Dis; 2014; 4(1):97-110. PubMed ID: 24496100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Subthalamic Deep Brain Stimulation on Upper Limb Dexterity in Patients with Parkinson Disease.
    Nozaki T; Asakawa T; Sugiyama K; Koda Y; Shimoda A; Mizushima T; Sameshima T; Namba H
    World Neurosurg; 2018 Jul; 115():e206-e217. PubMed ID: 29654953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in intracortical inhibition and clinical symptoms after STN-DBS in Parkinson's disease.
    Kobayashi M; Ohira T; Mihara B; Fujimaki T
    Clin Neurophysiol; 2016 Apr; 127(4):2031-7. PubMed ID: 26971486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor.
    Diamond A; Shahed J; Jankovic J
    J Neurol Sci; 2007 Sep; 260(1-2):199-203. PubMed ID: 17561121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual threshold neural closed loop deep brain stimulation in Parkinson disease patients.
    Velisar A; Syrkin-Nikolau J; Blumenfeld Z; Trager MH; Afzal MF; Prabhakar V; Bronte-Stewart H
    Brain Stimul; 2019; 12(4):868-876. PubMed ID: 30833216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance.
    Bejjani BP; Dormont D; Pidoux B; Yelnik J; Damier P; Arnulf I; Bonnet AM; Marsault C; Agid Y; Philippon J; Cornu P
    J Neurosurg; 2000 Apr; 92(4):615-25. PubMed ID: 10761650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of stimulation frequency on immediate freezing of gait in newly activated STN DBS in Parkinson's disease.
    Xie T; Kang UJ; Warnke P
    J Neurol Neurosurg Psychiatry; 2012 Oct; 83(10):1015-7. PubMed ID: 22696586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compensatory stepping in Parkinson's disease is still a problem after deep brain stimulation randomized to STN or GPi.
    St George RJ; Carlson-Kuhta P; King LA; Burchiel KJ; Horak FB
    J Neurophysiol; 2015 Sep; 114(3):1417-23. PubMed ID: 26108960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescue levodopa-carbidopa intestinal gel (LCIG) therapy in Parkinson's disease patients with suboptimal response to deep brain stimulation.
    Elkouzi A; Ramirez-Zamora A; Zeilman P; Barabas M; Eisinger RS; Malaty IA; Okun MS; Almeida L
    Ann Clin Transl Neurol; 2019 Oct; 6(10):1989-1995. PubMed ID: 31518070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
    Mercado R; Constantoyannis C; Mandat T; Kumar A; Schulzer M; Stoessl AJ; Honey CR
    Mov Disord; 2006 Sep; 21(9):1457-61. PubMed ID: 16721750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.